

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glucocorticoid metabolic process (GO:0008211) | 7.88932340 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.17689160 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.17689160 |
| 4 | low-density lipoprotein particle clearance (GO:0034383) | 7.11603285 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.81871275 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.81871275 |
| 7 | androgen biosynthetic process (GO:0006702) | 6.62894696 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.51131931 |
| 9 | C21-steroid hormone biosynthetic process (GO:0006700) | 6.41795890 |
| 10 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 6.02277275 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.94201742 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.94201742 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.94201742 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.82664654 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.78167637 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.74428493 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.62446782 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.46954133 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.44835006 |
| 20 | urea metabolic process (GO:0019627) | 5.29996236 |
| 21 | urea cycle (GO:0000050) | 5.29996236 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.24033033 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.22721616 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 5.21098484 |
| 25 | protein carboxylation (GO:0018214) | 5.15607578 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.15607578 |
| 27 | cysteine metabolic process (GO:0006534) | 5.14621979 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.14261801 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.07860786 |
| 30 | regulation of fibrinolysis (GO:0051917) | 5.04617722 |
| 31 | cellular response to antibiotic (GO:0071236) | 5.02382543 |
| 32 | progesterone metabolic process (GO:0042448) | 5.00732423 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.93815900 |
| 34 | response to follicle-stimulating hormone (GO:0032354) | 4.90490180 |
| 35 | bile acid metabolic process (GO:0008206) | 4.87565047 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 4.87172910 |
| 37 | cellular response to epinephrine stimulus (GO:0071872) | 4.85740251 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 4.83392862 |
| 39 | regulation of complement activation (GO:0030449) | 4.83245499 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.74488128 |
| 41 | estrogen biosynthetic process (GO:0006703) | 4.74184737 |
| 42 | C21-steroid hormone metabolic process (GO:0008207) | 4.73360174 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.69743733 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.66645759 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.57104764 |
| 46 | cellular response to growth hormone stimulus (GO:0071378) | 4.57059454 |
| 47 | reverse cholesterol transport (GO:0043691) | 4.55186712 |
| 48 | lysine metabolic process (GO:0006553) | 4.53308322 |
| 49 | lysine catabolic process (GO:0006554) | 4.53308322 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.53009912 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.47277659 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.47277659 |
| 53 | plasma lipoprotein particle remodeling (GO:0034369) | 4.46163993 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 4.46163993 |
| 55 | macromolecular complex remodeling (GO:0034367) | 4.46163993 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 4.46002792 |
| 57 | cellular response to gonadotropin stimulus (GO:0071371) | 4.45656452 |
| 58 | phospholipid efflux (GO:0033700) | 4.44784164 |
| 59 | regulation of cholesterol esterification (GO:0010872) | 4.40517452 |
| 60 | bile acid and bile salt transport (GO:0015721) | 4.34021450 |
| 61 | coenzyme catabolic process (GO:0009109) | 4.32929188 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 4.23767982 |
| 63 | cellular ketone body metabolic process (GO:0046950) | 4.20720241 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 4.19363377 |
| 65 | amine catabolic process (GO:0009310) | 4.15657416 |
| 66 | cellular biogenic amine catabolic process (GO:0042402) | 4.15657416 |
| 67 | cellular glucuronidation (GO:0052695) | 4.13438724 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 4.13275561 |
| 69 | negative regulation of sterol transport (GO:0032372) | 4.12981722 |
| 70 | negative regulation of cholesterol transport (GO:0032375) | 4.12981722 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 4.11871198 |
| 72 | ethanol oxidation (GO:0006069) | 4.06330512 |
| 73 | Leydig cell differentiation (GO:0033327) | 4.05082935 |
| 74 | glycine metabolic process (GO:0006544) | 4.01595110 |
| 75 | cholesterol efflux (GO:0033344) | 3.99526337 |
| 76 | glutamate metabolic process (GO:0006536) | 3.95423230 |
| 77 | cellular modified amino acid catabolic process (GO:0042219) | 3.93875792 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 3.91454044 |
| 79 | response to epinephrine (GO:0071871) | 3.90684337 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.88808859 |
| 81 | response to gonadotropin (GO:0034698) | 3.87647987 |
| 82 | fibrinolysis (GO:0042730) | 3.86770550 |
| 83 | acetyl-CoA metabolic process (GO:0006084) | 3.77642562 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.77227468 |
| 85 | low-density lipoprotein particle remodeling (GO:0034374) | 3.74304329 |
| 86 | phospholipid homeostasis (GO:0055091) | 3.74106697 |
| 87 | negative regulation of lipase activity (GO:0060192) | 3.72698787 |
| 88 | arginine metabolic process (GO:0006525) | 3.72518377 |
| 89 | short-chain fatty acid metabolic process (GO:0046459) | 3.71881894 |
| 90 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.71324065 |
| 91 | protein heterotrimerization (GO:0070208) | 3.69333133 |
| 92 | glucuronate metabolic process (GO:0019585) | 3.68053183 |
| 93 | uronic acid metabolic process (GO:0006063) | 3.68053183 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.67914289 |
| 95 | plasma lipoprotein particle assembly (GO:0034377) | 3.67067033 |
| 96 | drug catabolic process (GO:0042737) | 3.66951507 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 3.66457908 |
| 98 | organic acid catabolic process (GO:0016054) | 3.66457908 |
| 99 | aldehyde catabolic process (GO:0046185) | 3.65228820 |
| 100 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.64503809 |
| 101 | serine family amino acid biosynthetic process (GO:0009070) | 3.62790605 |
| 102 | ketone body metabolic process (GO:1902224) | 3.62447477 |
| 103 | hemidesmosome assembly (GO:0031581) | 3.61651688 |
| 104 | blood coagulation, intrinsic pathway (GO:0007597) | 3.61501334 |
| 105 | cytolysis (GO:0019835) | 3.61409288 |
| 106 | cofactor catabolic process (GO:0051187) | 3.61011605 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.60779561 |
| 108 | regulation of bile acid biosynthetic process (GO:0070857) | 3.60368646 |
| 109 | complement activation (GO:0006956) | 3.57795240 |
| 110 | complement activation, classical pathway (GO:0006958) | 3.57628848 |
| 111 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.56570932 |
| 112 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.56546143 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.56546143 |
| 114 | protein activation cascade (GO:0072376) | 3.55998160 |
| 115 | sterol homeostasis (GO:0055092) | 3.54543853 |
| 116 | adhesion of symbiont to host (GO:0044406) | 3.53841771 |
| 117 | regulation of cholesterol homeostasis (GO:2000188) | 3.51852827 |
| 118 | hormone biosynthetic process (GO:0042446) | 3.51780821 |
| 119 | fatty acid oxidation (GO:0019395) | 3.47334013 |
| 120 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.47313136 |
| 121 | monocarboxylic acid catabolic process (GO:0072329) | 3.47222000 |
| 122 | 2-oxoglutarate metabolic process (GO:0006103) | 3.46806944 |
| 123 | fatty acid beta-oxidation (GO:0006635) | 3.46515263 |
| 124 | regulation of cholesterol storage (GO:0010885) | 3.46405136 |
| 125 | cellular response to toxic substance (GO:0097237) | 3.42037625 |
| 126 | cellular response to cadmium ion (GO:0071276) | 3.38330789 |
| 127 | cell-substrate junction assembly (GO:0007044) | 3.26206587 |
| 128 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.22473698 |
| 129 | cell adhesion mediated by integrin (GO:0033627) | 3.21685687 |
| 130 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.20531853 |
| 131 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.14078692 |
| 132 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.13447132 |
| 133 | response to hepatocyte growth factor (GO:0035728) | 3.13447132 |
| 134 | regulation of gonadotropin secretion (GO:0032276) | 3.12136132 |
| 135 | regulation of steroid hormone biosynthetic process (GO:0090030) | 3.09718499 |
| 136 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.09212781 |
| 137 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.03270805 |
| 138 | androgen metabolic process (GO:0008209) | 3.02918668 |
| 139 | response to water (GO:0009415) | 3.02292795 |
| 140 | phagocytosis, recognition (GO:0006910) | 3.02238028 |
| 141 | mesodermal cell differentiation (GO:0048333) | 3.02126576 |
| 142 | response to insecticide (GO:0017085) | 3.01185143 |
| 143 | negative regulation of fatty acid transport (GO:2000192) | 2.99084584 |
| 144 | endocrine hormone secretion (GO:0060986) | 2.98490658 |
| 145 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.97698910 |
| 146 | toxin metabolic process (GO:0009404) | 2.96531469 |
| 147 | response to corticosterone (GO:0051412) | 2.95169029 |
| 148 | triglyceride catabolic process (GO:0019433) | 2.93597669 |
| 149 | protein localization to endosome (GO:0036010) | 2.92995206 |
| 150 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.91739140 |
| 151 | extracellular matrix assembly (GO:0085029) | 2.90250784 |
| 152 | biotin metabolic process (GO:0006768) | 2.84540633 |
| 153 | chondrocyte proliferation (GO:0035988) | 2.84311002 |
| 154 | stress fiber assembly (GO:0043149) | 2.82375849 |
| 155 | cellular response to monoamine stimulus (GO:0071868) | 2.80602669 |
| 156 | cellular response to catecholamine stimulus (GO:0071870) | 2.80602669 |
| 157 | endothelial cell chemotaxis (GO:0035767) | 2.79440175 |
| 158 | response to phenylpropanoid (GO:0080184) | 2.78878406 |
| 159 | skin morphogenesis (GO:0043589) | 2.76568218 |
| 160 | blood vessel endothelial cell migration (GO:0043534) | 2.76092297 |
| 161 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.73455887 |
| 162 | positive regulation of hormone metabolic process (GO:0032352) | 2.73016319 |
| 163 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.72836377 |
| 164 | desmosome organization (GO:0002934) | 2.72358148 |
| 165 | adrenal gland development (GO:0030325) | 2.71904002 |
| 166 | iron ion import (GO:0097286) | 2.71714181 |
| 167 | adherens junction assembly (GO:0034333) | 2.69686188 |
| 168 | cellular response to vitamin (GO:0071295) | 2.68429571 |
| 169 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.67376478 |
| 170 | focal adhesion assembly (GO:0048041) | 2.67372309 |
| 171 | cell-substrate adherens junction assembly (GO:0007045) | 2.67372309 |
| 172 | substrate-dependent cell migration (GO:0006929) | 2.66362522 |
| 173 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.65174339 |
| 174 | apoptotic cell clearance (GO:0043277) | 2.64917933 |
| 175 | endodermal cell differentiation (GO:0035987) | 2.61481702 |
| 176 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.61212350 |
| 177 | regulation of sequestering of triglyceride (GO:0010889) | 2.60860830 |
| 178 | neutral lipid catabolic process (GO:0046461) | 2.60593710 |
| 179 | acylglycerol catabolic process (GO:0046464) | 2.60593710 |
| 180 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.59792245 |
| 181 | negative regulation of macrophage differentiation (GO:0045650) | 2.58876165 |
| 182 | regulation of apoptotic cell clearance (GO:2000425) | 2.58845210 |
| 183 | response to mineralocorticoid (GO:0051385) | 2.56707892 |
| 184 | ovulation (GO:0030728) | 2.56662754 |
| 185 | intracellular lipid transport (GO:0032365) | 2.51495089 |
| 186 | response to growth hormone (GO:0060416) | 2.50912604 |
| 187 | import into cell (GO:0098657) | 2.49555240 |
| 188 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.48521300 |
| 189 | growth hormone receptor signaling pathway (GO:0060396) | 2.47943960 |
| 190 | positive regulation of cholesterol efflux (GO:0010875) | 2.47542344 |
| 191 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.44247866 |
| 192 | positive regulation of male gonad development (GO:2000020) | 2.43393836 |
| 193 | protein localization to cell surface (GO:0034394) | 2.43123581 |
| 194 | cellular response to interferon-alpha (GO:0035457) | 2.42888358 |
| 195 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.41731327 |
| 196 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.41561824 |
| 197 | glucocorticoid biosynthetic process (GO:0006704) | 10.4460593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.75200225 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.65502305 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.41570423 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.11467705 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.02903815 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.90188921 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.44647819 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93501391 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.36054671 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.10456739 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.28209751 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08551316 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8917578 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.91731736 |
| 15 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.88396902 |
| 16 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.87550722 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.76249260 |
| 18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.75875371 |
| 19 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.75576505 |
| 20 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.71663373 |
| 21 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.71663373 |
| 22 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.68047112 |
| 23 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.65788676 |
| 24 | CJUN_26792858_Chip-Seq_BT549_Human | 1.63904362 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63350294 |
| 26 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.61555723 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60940867 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55367981 |
| 29 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.51528336 |
| 30 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.47907154 |
| 31 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.44628849 |
| 32 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.41982582 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41715028 |
| 34 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.39613464 |
| 35 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.37696986 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37017687 |
| 37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35429939 |
| 38 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.33338151 |
| 39 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31360439 |
| 40 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.30641362 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30050913 |
| 42 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.29998458 |
| 43 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.29928599 |
| 44 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.29055982 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28156229 |
| 46 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.27983079 |
| 47 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.27659641 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.27596894 |
| 49 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.27387712 |
| 50 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26721488 |
| 51 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24892841 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23000474 |
| 53 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22913829 |
| 54 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21026792 |
| 55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.20888065 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20653041 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19920362 |
| 58 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15729376 |
| 59 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14265269 |
| 60 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.09202373 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.08348111 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07139538 |
| 63 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06824121 |
| 64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06319707 |
| 65 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05711006 |
| 66 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.04100444 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03638980 |
| 68 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03041338 |
| 69 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02882905 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01752511 |
| 71 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00264589 |
| 72 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99766599 |
| 73 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99239388 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98764571 |
| 75 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98604484 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98324642 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98135269 |
| 78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98119677 |
| 79 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.97499177 |
| 80 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97094929 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93449691 |
| 82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89067237 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89067237 |
| 84 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.88876432 |
| 85 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88810759 |
| 86 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.88589998 |
| 87 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88183001 |
| 88 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87071818 |
| 89 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85837862 |
| 90 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.84131746 |
| 91 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.83969236 |
| 92 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83450266 |
| 93 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83432649 |
| 94 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.82941701 |
| 95 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.82564168 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80940869 |
| 97 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.72299993 |
| 98 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72270678 |
| 99 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72016336 |
| 100 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.71139985 |
| 101 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.70290774 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.69884273 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.65585998 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.65557122 |
| 105 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.65523182 |
| 106 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.64341980 |
| 107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.64012996 |
| 108 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.63740206 |
| 109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62944979 |
| 110 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61774806 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61278933 |
| 112 | CBP_21632823_ChIP-Seq_H3396_Human | 0.60370969 |
| 113 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.59600200 |
| 114 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59453352 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.59218740 |
| 116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.58539773 |
| 117 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57641519 |
| 118 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57574032 |
| 119 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.56704246 |
| 120 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.54941560 |
| 121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.53701810 |
| 122 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.53280884 |
| 123 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53176304 |
| 124 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53002047 |
| 125 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.52874220 |
| 126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.52039704 |
| 127 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.52008883 |
| 128 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.52008883 |
| 129 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.51855013 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.51409801 |
| 131 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.50846671 |
| 132 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50089235 |
| 133 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.49536830 |
| 134 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.49446647 |
| 135 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.49376360 |
| 136 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.49254176 |
| 137 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.48997436 |
| 138 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48900431 |
| 139 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.48208902 |
| 140 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.48079873 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.47618964 |
| 142 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.46920741 |
| 143 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.46602887 |
| 144 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46599248 |
| 145 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.46346903 |
| 146 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.46010001 |
| 147 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45934165 |
| 148 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.45775052 |
| 149 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45576654 |
| 150 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.45105246 |
| 151 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.44988767 |
| 152 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.44410248 |
| 153 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.44368627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.00073010 |
| 2 | MP0005360_urolithiasis | 7.12215709 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.17957530 |
| 4 | MP0005365_abnormal_bile_salt | 5.98626549 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.73571475 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 4.60015204 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.00502415 |
| 8 | MP0003252_abnormal_bile_duct | 3.80456006 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.44444438 |
| 10 | MP0005083_abnormal_biliary_tract | 3.11252112 |
| 11 | MP0003566_abnormal_cell_adhesion | 3.06862668 |
| 12 | MP0004272_abnormal_basement_membrane | 2.88770945 |
| 13 | MP0009840_abnormal_foam_cell | 2.88500649 |
| 14 | MP0008004_abnormal_stomach_pH | 2.86828753 |
| 15 | MP0003279_aneurysm | 2.73139985 |
| 16 | MP0003195_calcinosis | 2.70550292 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.57782866 |
| 18 | MP0005332_abnormal_amino_acid | 2.57546018 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.40275281 |
| 20 | MP0003950_abnormal_plasma_membrane | 2.14959848 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.09684696 |
| 22 | MP0000609_abnormal_liver_physiology | 2.07891841 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 2.04882851 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.04266574 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.03631576 |
| 26 | MP0005375_adipose_tissue_phenotype | 1.98644893 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.97961823 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.91405141 |
| 29 | MP0003868_abnormal_feces_composition | 1.86722049 |
| 30 | MP0005503_abnormal_tendon_morphology | 1.85484718 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.85454455 |
| 32 | MP0005451_abnormal_body_composition | 1.81009811 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.77675464 |
| 34 | MP0003091_abnormal_cell_migration | 1.74373792 |
| 35 | MP0005023_abnormal_wound_healing | 1.73574400 |
| 36 | MP0006138_congestive_heart_failure | 1.66608046 |
| 37 | MP0001879_abnormal_lymphatic_vessel | 1.63906755 |
| 38 | MP0005409_darkened_coat_color | 1.63082076 |
| 39 | MP0002896_abnormal_bone_mineralization | 1.63029615 |
| 40 | MP0001958_emphysema | 1.61818958 |
| 41 | MP0009697_abnormal_copulation | 1.56751042 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52774358 |
| 43 | MP0000003_abnormal_adipose_tissue | 1.49919372 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.49361961 |
| 45 | MP0001764_abnormal_homeostasis | 1.47901220 |
| 46 | MP0002006_tumorigenesis | 1.44774322 |
| 47 | MP0005623_abnormal_meninges_morphology | 1.40591843 |
| 48 | MP0003011_delayed_dark_adaptation | 1.40350729 |
| 49 | MP0000751_myopathy | 1.39981955 |
| 50 | MP0005595_abnormal_vascular_smooth | 1.37920756 |
| 51 | MP0003941_abnormal_skin_development | 1.37319527 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.33242564 |
| 53 | MP0005076_abnormal_cell_differentiation | 1.31137507 |
| 54 | MP0000767_abnormal_smooth_muscle | 1.30887770 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.26036553 |
| 56 | MP0003959_abnormal_lean_body | 1.26015184 |
| 57 | MP0005164_abnormal_response_to | 1.25702777 |
| 58 | MP0004130_abnormal_muscle_cell | 1.25349257 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.25257531 |
| 60 | MP0002933_joint_inflammation | 1.23936095 |
| 61 | MP0002877_abnormal_melanocyte_morpholog | 1.22677483 |
| 62 | MP0004084_abnormal_cardiac_muscle | 1.21000020 |
| 63 | MP0002254_reproductive_system_inflammat | 1.20775493 |
| 64 | MP0005508_abnormal_skeleton_morphology | 1.19307944 |
| 65 | MP0005647_abnormal_sex_gland | 1.18347034 |
| 66 | MP0002009_preneoplasia | 1.17477909 |
| 67 | MP0003186_abnormal_redox_activity | 1.17405988 |
| 68 | MP0009643_abnormal_urine_homeostasis | 1.16969580 |
| 69 | MP0002108_abnormal_muscle_morphology | 1.16227652 |
| 70 | MP0005670_abnormal_white_adipose | 1.14753230 |
| 71 | MP0010368_abnormal_lymphatic_system | 1.14552508 |
| 72 | MP0002796_impaired_skin_barrier | 1.14343600 |
| 73 | MP0002970_abnormal_white_adipose | 1.12491112 |
| 74 | MP0009764_decreased_sensitivity_to | 1.08284989 |
| 75 | MP0000598_abnormal_liver_morphology | 1.07156132 |
| 76 | MP0001881_abnormal_mammary_gland | 0.99105055 |
| 77 | MP0003828_pulmonary_edema | 0.98246357 |
| 78 | MP0005257_abnormal_intraocular_pressure | 0.97126410 |
| 79 | MP0002971_abnormal_brown_adipose | 0.96917492 |
| 80 | MP0002295_abnormal_pulmonary_circulatio | 0.96511591 |
| 81 | MP0009763_increased_sensitivity_to | 0.92526738 |
| 82 | MP0000762_abnormal_tongue_morphology | 0.91955302 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.91477931 |
| 84 | MP0006036_abnormal_mitochondrial_physio | 0.90981741 |
| 85 | MP0000627_abnormal_mammary_gland | 0.90436816 |
| 86 | MP0000604_amyloidosis | 0.89533830 |
| 87 | MP0000249_abnormal_blood_vessel | 0.89077315 |
| 88 | MP0004381_abnormal_hair_follicle | 0.88677746 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.88466973 |
| 90 | MP0004858_abnormal_nervous_system | 0.88094103 |
| 91 | MP0001915_intracranial_hemorrhage | 0.84001084 |
| 92 | MP0008469_abnormal_protein_level | 0.83383279 |
| 93 | MP0005165_increased_susceptibility_to | 0.81891084 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.81758997 |
| 95 | MP0000733_abnormal_muscle_development | 0.81446454 |
| 96 | MP0002128_abnormal_blood_circulation | 0.81262996 |
| 97 | MP0001614_abnormal_blood_vessel | 0.80387167 |
| 98 | MP0009642_abnormal_blood_homeostasis | 0.80221186 |
| 99 | MP0002078_abnormal_glucose_homeostasis | 0.79361934 |
| 100 | MP0005334_abnormal_fat_pad | 0.79273184 |
| 101 | MP0004233_abnormal_muscle_weight | 0.78407815 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.77892276 |
| 103 | MP0004883_abnormal_blood_vessel | 0.77390132 |
| 104 | MP0002837_dystrophic_cardiac_calcinosis | 0.76782147 |
| 105 | MP0000163_abnormal_cartilage_morphology | 0.76601793 |
| 106 | MP0000467_abnormal_esophagus_morphology | 0.76336766 |
| 107 | MP0005390_skeleton_phenotype | 0.76025911 |
| 108 | MP0005408_hypopigmentation | 0.75988997 |
| 109 | MP0005220_abnormal_exocrine_pancreas | 0.74497425 |
| 110 | MP0004036_abnormal_muscle_relaxation | 0.74071919 |
| 111 | MP0005376_homeostasis/metabolism_phenot | 0.73231761 |
| 112 | MP0005084_abnormal_gallbladder_morpholo | 0.73062042 |
| 113 | MP0009250_abnormal_appendicular_skeleto | 0.73033702 |
| 114 | MP0000579_abnormal_nail_morphology | 0.72570731 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.72409843 |
| 116 | MP0001533_abnormal_skeleton_physiology | 0.72178976 |
| 117 | MP0010771_integument_phenotype | 0.70828390 |
| 118 | MP0001849_ear_inflammation | 0.70704312 |
| 119 | MP0001661_extended_life_span | 0.70592699 |
| 120 | MP0006054_spinal_hemorrhage | 0.70140232 |
| 121 | MP0000343_altered_response_to | 0.69719850 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.69615972 |
| 123 | MP0002115_abnormal_skeleton_extremities | 0.68779694 |
| 124 | MP0005535_abnormal_body_temperature | 0.68042821 |
| 125 | MP0009765_abnormal_xenobiotic_induced | 0.67585062 |
| 126 | MP0005266_abnormal_metabolism | 0.66373006 |
| 127 | MP0003724_increased_susceptibility_to | 0.64785248 |
| 128 | MP0002060_abnormal_skin_morphology | 0.60559680 |
| 129 | MP0004185_abnormal_adipocyte_glucose | 0.60007835 |
| 130 | MP0010234_abnormal_vibrissa_follicle | 0.58655305 |
| 131 | MP0002269_muscular_atrophy | 0.58530344 |
| 132 | MP0003690_abnormal_glial_cell | 0.57933667 |
| 133 | MP0006035_abnormal_mitochondrial_morpho | 0.57905247 |
| 134 | MP0005448_abnormal_energy_balance | 0.56801300 |
| 135 | MP0000427_abnormal_hair_cycle | 0.52553066 |
| 136 | MP0009053_abnormal_anal_canal | 0.51937938 |
| 137 | MP0001756_abnormal_urination | 0.51696643 |
| 138 | MP0005275_abnormal_skin_tensile | 0.50164742 |
| 139 | MP0005501_abnormal_skin_physiology | 0.48864239 |
| 140 | MP0003646_muscle_fatigue | 0.48769861 |
| 141 | MP0003453_abnormal_keratinocyte_physiol | 0.45677545 |
| 142 | MP0001243_abnormal_dermal_layer | 0.45593989 |
| 143 | MP0003329_amyloid_beta_deposits | 0.43359215 |
| 144 | MP0004947_skin_inflammation | 0.42990849 |
| 145 | MP0000639_abnormal_adrenal_gland | 0.42227588 |
| 146 | MP0002928_abnormal_bile_duct | 0.41990881 |
| 147 | MP0000749_muscle_degeneration | 0.41883727 |
| 148 | MP0005395_other_phenotype | 0.41594620 |
| 149 | MP0000747_muscle_weakness | 0.41120014 |
| 150 | MP0000647_abnormal_sebaceous_gland | 0.40914629 |
| 151 | MP0002136_abnormal_kidney_physiology | 0.39901061 |
| 152 | MP0005464_abnormal_platelet_physiology | 0.39842619 |
| 153 | MP0009115_abnormal_fat_cell | 0.39684333 |
| 154 | MP0004145_abnormal_muscle_electrophysio | 0.39239240 |
| 155 | MP0003638_abnormal_response/metabolism_ | 0.38714517 |
| 156 | MP0000230_abnormal_systemic_arterial | 0.37279856 |
| 157 | MP0009672_abnormal_birth_weight | 0.37089715 |
| 158 | MP0003436_decreased_susceptibility_to | 0.36559826 |
| 159 | MP0005248_abnormal_Harderian_gland | 0.36225675 |
| 160 | MP0009384_cardiac_valve_regurgitation | 0.36199020 |
| 161 | MP0008874_decreased_physiological_sensi | 0.34797588 |
| 162 | MP0002168_other_aberrant_phenotype | 0.34377881 |
| 163 | MP0003953_abnormal_hormone_level | 0.34140760 |
| 164 | MP0001216_abnormal_epidermal_layer | 0.34062608 |
| 165 | MP0003075_altered_response_to | 0.33939388 |
| 166 | MP0008873_increased_physiological_sensi | 0.33124739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.14250884 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.02210071 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.78289070 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.18028960 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.17415793 |
| 6 | Xanthomatosis (HP:0000991) | 6.02024628 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.95722755 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.29793798 |
| 9 | Complement deficiency (HP:0004431) | 5.23312181 |
| 10 | Protrusio acetabuli (HP:0003179) | 4.87074287 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.69321560 |
| 12 | Joint hemorrhage (HP:0005261) | 4.54703604 |
| 13 | Epidermoid cyst (HP:0200040) | 4.52581938 |
| 14 | Hyperammonemia (HP:0001987) | 4.41796937 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.32479212 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.29318180 |
| 17 | Hyperglycinemia (HP:0002154) | 4.26423317 |
| 18 | Ketosis (HP:0001946) | 4.23993672 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 4.13987330 |
| 20 | Cervical subluxation (HP:0003308) | 4.09366589 |
| 21 | Premature rupture of membranes (HP:0001788) | 4.04815695 |
| 22 | Fat malabsorption (HP:0002630) | 4.02795375 |
| 23 | Vascular tortuosity (HP:0004948) | 4.00893422 |
| 24 | Arterial tortuosity (HP:0005116) | 3.97159527 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.95551697 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.95344578 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.92273929 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.86673098 |
| 29 | Hyperglycinuria (HP:0003108) | 3.83550580 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.81545230 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.81545230 |
| 32 | Hypoglycemic coma (HP:0001325) | 3.80732697 |
| 33 | Abnormality of complement system (HP:0005339) | 3.77692945 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.61266478 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.61010385 |
| 36 | Hypercholesterolemia (HP:0003124) | 3.42376634 |
| 37 | Enlarged penis (HP:0000040) | 3.41979824 |
| 38 | Renal salt wasting (HP:0000127) | 3.34931482 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32903476 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.29638488 |
| 41 | Ankle contracture (HP:0006466) | 3.24973993 |
| 42 | Decreased circulating renin level (HP:0003351) | 3.24101877 |
| 43 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.21090382 |
| 44 | Hyperbilirubinemia (HP:0002904) | 3.15901971 |
| 45 | Acanthosis nigricans (HP:0000956) | 3.15083913 |
| 46 | Aortic aneurysm (HP:0004942) | 3.11612951 |
| 47 | Ketoacidosis (HP:0001993) | 3.08457841 |
| 48 | Steatorrhea (HP:0002570) | 3.07055907 |
| 49 | Abnormality of carpal bone ossification (HP:0006257) | 3.05669392 |
| 50 | Spinal rigidity (HP:0003306) | 3.00249464 |
| 51 | Overgrowth (HP:0001548) | 2.99407125 |
| 52 | Wormian bones (HP:0002645) | 2.99200205 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.97779418 |
| 54 | Myocardial infarction (HP:0001658) | 2.95598880 |
| 55 | Abnormality of serum amino acid levels (HP:0003112) | 2.93510371 |
| 56 | Relative macrocephaly (HP:0004482) | 2.88315418 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.86123936 |
| 58 | Delayed CNS myelination (HP:0002188) | 2.85871520 |
| 59 | Aortic dissection (HP:0002647) | 2.78744610 |
| 60 | Hepatocellular carcinoma (HP:0001402) | 2.78713563 |
| 61 | Hyperaldosteronism (HP:0000859) | 2.78277388 |
| 62 | Metabolic acidosis (HP:0001942) | 2.77236503 |
| 63 | Atrophic scars (HP:0001075) | 2.69214846 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.68950106 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.67182594 |
| 66 | Abnormal ossification of hand bones (HP:0005921) | 2.66129903 |
| 67 | Spontaneous abortion (HP:0005268) | 2.65266416 |
| 68 | Vascular calcification (HP:0004934) | 2.65198862 |
| 69 | Abnormal gallbladder morphology (HP:0012437) | 2.65023860 |
| 70 | Soft skin (HP:0000977) | 2.63149965 |
| 71 | Skin nodule (HP:0200036) | 2.62950423 |
| 72 | Cholelithiasis (HP:0001081) | 2.61081196 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60199869 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.60199869 |
| 75 | Shallow orbits (HP:0000586) | 2.59872187 |
| 76 | Fragile skin (HP:0001030) | 2.59352521 |
| 77 | Vertebral compression fractures (HP:0002953) | 2.59077863 |
| 78 | Follicular hyperkeratosis (HP:0007502) | 2.57586513 |
| 79 | Gout (HP:0001997) | 2.55782689 |
| 80 | Increased variability in muscle fiber diameter (HP:0003557) | 2.54481790 |
| 81 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.52984079 |
| 82 | Osteolytic defects of the hand bones (HP:0009699) | 2.52984079 |
| 83 | Syringomyelia (HP:0003396) | 2.49815467 |
| 84 | Spinal cord lesions (HP:0100561) | 2.49815467 |
| 85 | Bronchomalacia (HP:0002780) | 2.48222757 |
| 86 | Bladder diverticulum (HP:0000015) | 2.48078538 |
| 87 | Lethargy (HP:0001254) | 2.46952260 |
| 88 | Ulnar bowing (HP:0003031) | 2.42535288 |
| 89 | Hypoglycemic seizures (HP:0002173) | 2.41781581 |
| 90 | Acanthocytosis (HP:0001927) | 2.39970722 |
| 91 | Abnormal hand bone ossification (HP:0010660) | 2.39707044 |
| 92 | Ankyloglossia (HP:0010296) | 2.39431115 |
| 93 | Cardiovascular calcification (HP:0011915) | 2.37269741 |
| 94 | Broad face (HP:0000283) | 2.36808691 |
| 95 | Cerebral edema (HP:0002181) | 2.34963898 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 2.34296429 |
| 97 | Cholecystitis (HP:0001082) | 2.34296429 |
| 98 | Mitral stenosis (HP:0001718) | 2.30374518 |
| 99 | Short nail (HP:0001799) | 2.29811012 |
| 100 | Esophageal varix (HP:0002040) | 2.29586302 |
| 101 | Neonatal onset (HP:0003623) | 2.29573360 |
| 102 | Glomerulonephritis (HP:0000099) | 2.28495865 |
| 103 | Persistence of primary teeth (HP:0006335) | 2.27040140 |
| 104 | Short humerus (HP:0005792) | 2.22938073 |
| 105 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.22679772 |
| 106 | Accelerated skeletal maturation (HP:0005616) | 2.22246106 |
| 107 | Increased connective tissue (HP:0009025) | 2.21079098 |
| 108 | Joint laxity (HP:0001388) | 2.20623091 |
| 109 | Myoglobinuria (HP:0002913) | 2.20386446 |
| 110 | Spinal cord compression (HP:0002176) | 2.17219376 |
| 111 | Malnutrition (HP:0004395) | 2.13105793 |
| 112 | Abnormality of oral frenula (HP:0000190) | 2.12569359 |
| 113 | Flat acetabular roof (HP:0003180) | 2.12480805 |
| 114 | Blue sclerae (HP:0000592) | 2.12467439 |
| 115 | Late onset (HP:0003584) | 2.12165209 |
| 116 | Abnormality of the gallbladder (HP:0005264) | 2.11569839 |
| 117 | Spastic diplegia (HP:0001264) | 2.11328394 |
| 118 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.09268529 |
| 119 | Pancreatitis (HP:0001733) | 2.09204028 |
| 120 | Hemorrhage of the eye (HP:0011885) | 2.09011464 |
| 121 | Irritability (HP:0000737) | 2.08655123 |
| 122 | Amyloidosis (HP:0011034) | 2.08298037 |
| 123 | Short clavicles (HP:0000894) | 2.07744925 |
| 124 | Cerebral aneurysm (HP:0004944) | 2.07299538 |
| 125 | Wrist flexion contracture (HP:0001239) | 2.06200895 |
| 126 | Gingival bleeding (HP:0000225) | 2.05004167 |
| 127 | Coxa vara (HP:0002812) | 2.04356369 |
| 128 | Broad metatarsal (HP:0001783) | 2.01652660 |
| 129 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01310422 |
| 130 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.00589684 |
| 131 | Exercise-induced myalgia (HP:0003738) | 2.00583107 |
| 132 | Brushfield spots (HP:0001088) | 2.00172868 |
| 133 | Menorrhagia (HP:0000132) | 2.00076166 |
| 134 | Vomiting (HP:0002013) | 1.99773463 |
| 135 | Aneurysm (HP:0002617) | 1.99164582 |
| 136 | Large earlobe (HP:0009748) | 1.97641808 |
| 137 | Hyperuricemia (HP:0002149) | 1.97496029 |
| 138 | Increased purine levels (HP:0004368) | 1.97496029 |
| 139 | Enlarged kidneys (HP:0000105) | 1.96607402 |
| 140 | Sensorimotor neuropathy (HP:0007141) | 1.96242235 |
| 141 | Hypoplasia of the uterus (HP:0000013) | 1.95740427 |
| 142 | Opisthotonus (HP:0002179) | 1.94758731 |
| 143 | Aortic valve stenosis (HP:0001650) | 1.93444692 |
| 144 | Generalized aminoaciduria (HP:0002909) | 1.93051912 |
| 145 | Adrenal overactivity (HP:0002717) | 1.92738337 |
| 146 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.91611699 |
| 147 | Renal cortical cysts (HP:0000803) | 1.90452361 |
| 148 | Thrombophlebitis (HP:0004418) | 1.90136400 |
| 149 | Dilatation of the ascending aorta (HP:0005111) | 1.90115082 |
| 150 | Abnormality of proline metabolism (HP:0010907) | 1.89395646 |
| 151 | Hydroxyprolinuria (HP:0003080) | 1.89395646 |
| 152 | Hyperglycemia (HP:0003074) | 1.89341225 |
| 153 | Precocious puberty (HP:0000826) | 1.88597568 |
| 154 | Rhizomelia (HP:0008905) | 1.88074135 |
| 155 | Mitral valve prolapse (HP:0001634) | 1.87789050 |
| 156 | Fragile nails (HP:0001808) | 1.86344027 |
| 157 | Poikilocytosis (HP:0004447) | 1.86327341 |
| 158 | Obstructive sleep apnea (HP:0002870) | 1.85752005 |
| 159 | Rickets (HP:0002748) | 1.85329203 |
| 160 | Vertebral arch anomaly (HP:0008438) | 1.85049562 |
| 161 | Oligomenorrhea (HP:0000876) | 1.84931805 |
| 162 | Rhabdomyolysis (HP:0003201) | 1.83613965 |
| 163 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.82943540 |
| 164 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.82523765 |
| 165 | Spondylolisthesis (HP:0003302) | 1.82216185 |
| 166 | Disproportionate tall stature (HP:0001519) | 1.81860114 |
| 167 | Abnormality of iron homeostasis (HP:0011031) | 1.81311573 |
| 168 | Advanced eruption of teeth (HP:0006288) | 1.80577046 |
| 169 | Genu recurvatum (HP:0002816) | 1.80387561 |
| 170 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78759104 |
| 171 | Neonatal death (HP:0003811) | 1.78361153 |
| 172 | Growth hormone excess (HP:0000845) | 1.78354772 |
| 173 | Striae distensae (HP:0001065) | 1.78200612 |
| 174 | Elevated hepatic transaminases (HP:0002910) | 1.77925278 |
| 175 | Mitral regurgitation (HP:0001653) | 1.77285258 |
| 176 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76955630 |
| 177 | Knee flexion contracture (HP:0006380) | 1.75917462 |
| 178 | Neurofibrillary tangles (HP:0002185) | 1.75860096 |
| 179 | Hypophosphatemic rickets (HP:0004912) | 1.74386266 |
| 180 | Cupped ribs (HP:0000887) | 1.74337602 |
| 181 | Abnormality of the acetabulum (HP:0003170) | 1.72666798 |
| 182 | Natal tooth (HP:0000695) | 1.72423222 |
| 183 | Ovoid vertebral bodies (HP:0003300) | 1.72333850 |
| 184 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.71561644 |
| 185 | Delayed cranial suture closure (HP:0000270) | 1.71221693 |
| 186 | Onycholysis (HP:0001806) | 1.71088806 |
| 187 | Aortic regurgitation (HP:0001659) | 1.70403959 |
| 188 | Ectopia lentis (HP:0001083) | 1.69048835 |
| 189 | Coarse hair (HP:0002208) | 1.67556611 |
| 190 | Coronal craniosynostosis (HP:0004440) | 1.67050302 |
| 191 | Broad ribs (HP:0000885) | 1.66770364 |
| 192 | Mucopolysacchariduria (HP:0008155) | 1.66425833 |
| 193 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.66425833 |
| 194 | Limited hip movement (HP:0008800) | 1.64327492 |
| 195 | Cerebral inclusion bodies (HP:0100314) | 1.63229365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.33474752 |
| 2 | SIK1 | 4.04079397 |
| 3 | ERN1 | 3.83772779 |
| 4 | AKT3 | 3.80038679 |
| 5 | FGFR4 | 3.64974650 |
| 6 | PDGFRA | 3.54634562 |
| 7 | INSRR | 3.15755714 |
| 8 | NTRK1 | 2.80135613 |
| 9 | PIK3CG | 2.75320523 |
| 10 | TAOK3 | 2.47177309 |
| 11 | DDR2 | 2.39615322 |
| 12 | MAP2K4 | 2.30062174 |
| 13 | OBSCN | 2.26709748 |
| 14 | ERBB4 | 2.22674613 |
| 15 | EPHA2 | 2.04857821 |
| 16 | MYLK | 1.96123705 |
| 17 | NEK9 | 1.93860462 |
| 18 | MST1R | 1.92981288 |
| 19 | LATS1 | 1.88613681 |
| 20 | TRIB3 | 1.84518766 |
| 21 | PRPF4B | 1.71504649 |
| 22 | MAP3K7 | 1.69229291 |
| 23 | PKN2 | 1.68100195 |
| 24 | MAP2K3 | 1.66873332 |
| 25 | MAPK11 | 1.65636305 |
| 26 | ICK | 1.65342394 |
| 27 | EEF2K | 1.65033513 |
| 28 | TYK2 | 1.62571675 |
| 29 | PDGFRB | 1.61269743 |
| 30 | TIE1 | 1.58201595 |
| 31 | KDR | 1.57078470 |
| 32 | PAK2 | 1.49823343 |
| 33 | PINK1 | 1.46593980 |
| 34 | TTN | 1.45289538 |
| 35 | PTK6 | 1.45043396 |
| 36 | PRKAA2 | 1.42257946 |
| 37 | FRK | 1.40980120 |
| 38 | PHKG1 | 1.32137506 |
| 39 | PHKG2 | 1.32137506 |
| 40 | STK38 | 1.27583992 |
| 41 | FLT3 | 1.26634934 |
| 42 | EPHB1 | 1.24965775 |
| 43 | MAPK12 | 1.24722856 |
| 44 | MAP3K3 | 1.22038300 |
| 45 | FGFR2 | 1.21678312 |
| 46 | CDC42BPA | 1.20539204 |
| 47 | MAP3K13 | 1.18843620 |
| 48 | PAK4 | 1.13837020 |
| 49 | ABL2 | 1.12263245 |
| 50 | MAP3K14 | 1.10631435 |
| 51 | JAK2 | 1.07281902 |
| 52 | RIPK1 | 1.07227765 |
| 53 | JAK1 | 1.06865373 |
| 54 | MELK | 1.05536730 |
| 55 | CDK12 | 1.05259156 |
| 56 | TBK1 | 1.01731794 |
| 57 | IRAK3 | 1.00720906 |
| 58 | EPHA3 | 1.00585918 |
| 59 | DAPK2 | 1.00217752 |
| 60 | PIK3CA | 0.98858152 |
| 61 | PRKD2 | 0.98364436 |
| 62 | TRPM7 | 0.95491912 |
| 63 | MAP2K6 | 0.95080158 |
| 64 | STK38L | 0.94733469 |
| 65 | TGFBR2 | 0.92481158 |
| 66 | CAMK1D | 0.89115902 |
| 67 | MAPK4 | 0.87886997 |
| 68 | PRKAA1 | 0.86666815 |
| 69 | TAOK2 | 0.85713051 |
| 70 | PTK2B | 0.85092539 |
| 71 | BMX | 0.81800784 |
| 72 | LMTK2 | 0.79191132 |
| 73 | ZAP70 | 0.76887150 |
| 74 | PRKD3 | 0.75722777 |
| 75 | DMPK | 0.73862297 |
| 76 | ERBB2 | 0.73466704 |
| 77 | MAPK15 | 0.73008256 |
| 78 | CDK6 | 0.71342961 |
| 79 | MAP3K11 | 0.70992759 |
| 80 | PRKCZ | 0.69667336 |
| 81 | FGFR3 | 0.67360849 |
| 82 | GSK3A | 0.67315905 |
| 83 | JAK3 | 0.65730762 |
| 84 | SCYL2 | 0.65326079 |
| 85 | CSK | 0.63524024 |
| 86 | PRKACG | 0.62859218 |
| 87 | CAMK2G | 0.62827642 |
| 88 | MAPK7 | 0.61673878 |
| 89 | PKN1 | 0.61144546 |
| 90 | RPS6KA2 | 0.60523878 |
| 91 | GRK1 | 0.59348548 |
| 92 | MAP3K10 | 0.58956535 |
| 93 | MAP3K5 | 0.58762998 |
| 94 | DYRK1B | 0.58584395 |
| 95 | MAPKAPK3 | 0.58235438 |
| 96 | MET | 0.57959241 |
| 97 | SGK3 | 0.57702898 |
| 98 | CAMK1 | 0.54301635 |
| 99 | PDK4 | 0.53357918 |
| 100 | PDK3 | 0.53357918 |
| 101 | PDPK1 | 0.48444063 |
| 102 | ROCK1 | 0.47746673 |
| 103 | SMG1 | 0.46008119 |
| 104 | SGK2 | 0.45463275 |
| 105 | PRKCQ | 0.45304167 |
| 106 | FER | 0.44297996 |
| 107 | ROCK2 | 0.43482769 |
| 108 | CLK1 | 0.42891934 |
| 109 | CAMK1G | 0.42789907 |
| 110 | PRKG2 | 0.42774633 |
| 111 | IKBKE | 0.42513789 |
| 112 | AKT2 | 0.42176016 |
| 113 | MAP3K6 | 0.39731456 |
| 114 | PDK2 | 0.39175149 |
| 115 | MAP2K1 | 0.39066283 |
| 116 | IGF1R | 0.38898838 |
| 117 | MAPK3 | 0.38788733 |
| 118 | MAP2K2 | 0.38181143 |
| 119 | MAP3K1 | 0.37733213 |
| 120 | SGK494 | 0.36829909 |
| 121 | SGK223 | 0.36829909 |
| 122 | STK3 | 0.35118276 |
| 123 | IRAK1 | 0.33910925 |
| 124 | PTK2 | 0.32341832 |
| 125 | KIT | 0.32201363 |
| 126 | CDK9 | 0.30539502 |
| 127 | CDK7 | 0.30482060 |
| 128 | RET | 0.30161252 |
| 129 | CSF1R | 0.30133590 |
| 130 | FGFR1 | 0.30108000 |
| 131 | MARK2 | 0.30017618 |
| 132 | MAPK1 | 0.29807823 |
| 133 | PRKCH | 0.29753806 |
| 134 | YES1 | 0.28740752 |
| 135 | GRK6 | 0.28290890 |
| 136 | MAP3K2 | 0.27826605 |
| 137 | WNK1 | 0.27786347 |
| 138 | EGFR | 0.27772951 |
| 139 | MAP3K12 | 0.27765943 |
| 140 | EPHB2 | 0.27595478 |
| 141 | INSR | 0.26422502 |
| 142 | SRC | 0.26377738 |
| 143 | IRAK2 | 0.26291014 |
| 144 | PBK | 0.26179171 |
| 145 | LATS2 | 0.26017266 |
| 146 | MTOR | 0.25893399 |
| 147 | PRKD1 | 0.24540100 |
| 148 | PDK1 | 0.24439796 |
| 149 | ABL1 | 0.23325570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.43410795 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.31112674 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26550152 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.17969019 |
| 5 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.97034233 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95340986 |
| 7 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 2.76121377 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.75294435 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.68040862 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67261075 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57537094 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55482004 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52108273 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40230909 |
| 15 | Focal adhesion_Homo sapiens_hsa04510 | 2.28609897 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20232044 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.17781634 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.11481477 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09732350 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08921696 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.06010850 |
| 22 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.98307947 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94144364 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.93972112 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.92347583 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87203237 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87059317 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85407784 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83500627 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75098590 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73966149 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73297902 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.69956226 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62600888 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.60290640 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.59595497 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57775696 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55625496 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53774607 |
| 40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.49089871 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47817458 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.46345279 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43228165 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41956462 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41383902 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37479139 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34980010 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.33594874 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.31053219 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22831663 |
| 51 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22125462 |
| 52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.18069533 |
| 53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15459025 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13188208 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12949700 |
| 56 | Adherens junction_Homo sapiens_hsa04520 | 1.12506573 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11662765 |
| 58 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.10966284 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09807557 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08691977 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08586176 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00346197 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98543516 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98407769 |
| 65 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.97252992 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97065734 |
| 67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97033415 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96704586 |
| 69 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.95585794 |
| 70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94267867 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92857230 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92567435 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92503149 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91309081 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.90065254 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89163205 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88812971 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88346080 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85794137 |
| 80 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.85744772 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85007655 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82062701 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.81391481 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77391905 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76639117 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75460895 |
| 87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74740850 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74225636 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.73319345 |
| 90 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71752884 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70806239 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70724663 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69311034 |
| 94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68357776 |
| 95 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.66952884 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66732204 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66704605 |
| 98 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.63903229 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63816706 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62674695 |
| 101 | Gap junction_Homo sapiens_hsa04540 | 0.62157340 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.62034368 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61900429 |
| 104 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60902255 |
| 105 | Melanogenesis_Homo sapiens_hsa04916 | 0.59746641 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.58408533 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58375182 |
| 108 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58018623 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57304239 |
| 110 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.55222099 |
| 111 | Platelet activation_Homo sapiens_hsa04611 | 0.54734490 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54236321 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54218698 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54014372 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53174069 |
| 116 | Melanoma_Homo sapiens_hsa05218 | 0.53114924 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52649182 |
| 118 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52477465 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.51810845 |
| 120 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51050438 |
| 121 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51039169 |
| 122 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50959899 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49520243 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48141638 |
| 125 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.47096689 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44956402 |
| 127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40826297 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39249907 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.39044526 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34304013 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.31183634 |
| 132 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30402467 |
| 133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25451792 |
| 134 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24713615 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21561578 |
| 136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19439052 |
| 137 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18878437 |
| 138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14684023 |
| 139 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02801605 |
| 140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02772238 |
| 141 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02463735 |
| 142 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1965532 |
| 143 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1885375 |
| 144 | Pertussis_Homo sapiens_hsa05133 | -0.1881355 |
| 145 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1743165 |
| 146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1648333 |
| 147 | Amoebiasis_Homo sapiens_hsa05146 | -0.1522888 |
| 148 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1495396 |
| 149 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1474540 |
| 150 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1407164 |
| 151 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1353939 |
| 152 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1335145 |
| 153 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1327114 |
| 154 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1319972 |
| 155 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1284883 |
| 156 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1168749 |
| 157 | Hepatitis C_Homo sapiens_hsa05160 | -0.1121359 |
| 158 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0658868 |
| 159 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0434686 |

